Quick Takeaways
- VANGUARD GROUP INC filed SCHEDULE 13G/A for X4 Pharmaceuticals Inc Common Stock (XFOR).
- Disclosed ownership: 4.8%.
- Date of event: 31 Dec 2024.
VANGUARD GROUP INC - 31 Dec 2024 SCHEDULE 13G/A Report for X4 Pharmaceuticals Inc Common Stock (XFOR)
- Filing Manager
- VANGUARD GROUP INC
- Reporting Manager
- The Vanguard Group
- Security
- X4 Pharmaceuticals Inc Common Stock
- Symbol
- XFOR
- Shares outstanding
- 170,852,146 shares
- Disclosed Ownership
- 8,200,903 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 31 Jan 2025, 10:09:25 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"VANGUARD GROUP INC disclosed 4.8% ownership in X4 Pharmaceuticals Inc Common Stock (XFOR) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 31 Jan 2025, 10:09.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Vanguard Group | 4.8% | 8,200,903 | 0 | 272,941 | Ashley Grim | Head of Global Fund Administration |